$187.71 meals Payment -- Bayer Healthcare to Dr. Daniel White

Bayer Healthcare provides $187.71 in meals to a Radiology physician for Tagrisso.

This page provides a detailed analysis of a $187.71 meals payment from Bayer Healthcare to Dr. Daniel White. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$187.71
Payment Typemeals
Payment NatureFood and Beverage
Pharmaceutical CompanyBayer Healthcare
PhysicianDr. Daniel White
NPI Number1249175023
Physician SpecialtyRadiology
LocationLansing, MI
Date of Payment2026-01-26
Related Drug/DeviceTagrisso
Conflict AssessmentLow -- Routine

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Bayer Healthcare made a $187.71 meals payment to Daniel White, a Radiology specialist in Lansing, MI. The payment was associated with Tagrisso. The payment of $187.71 from Bayer Healthcare to Dr. Daniel White was for meals related to the drug Tagrisso. This payment occurred on January 26, 2026, in Lansing, MI. The payment was categorized as 'Food and Beverage' under the 'meals' payment type.

Patient Guidance: What This Payment Means for You

This payment was for a meal provided by a pharmaceutical company, which may be related to information about a medication. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Meals provided by pharmaceutical companies to physicians are common, but the context of this specific meal in relation to Radiology and Tagrisso is not immediately clear without further information.

Regulatory Context: Sunshine Act Requirements

Payments from pharmaceutical manufacturers to physicians are subject to disclosure under the Open Payments program to ensure transparency in healthcare.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding meals Payments

Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.

Frequently Asked Questions About This Payment

What was this $187.71 payment for?

This was a meals payment of $187.71 from Bayer Healthcare to Daniel White, categorized as "Food and Beverage". It was associated with Tagrisso. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Daniel White accept pharmaceutical money?

Yes, Daniel White received this $187.71 payment from Bayer Healthcare. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Daniel White's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this meals payment?

A meals payment of $187.71 is generally routine and common in the industry. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Radiology?

To compare this payment against Radiology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Radiology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Daniel White's relationship with Bayer Healthcare?

The payment amount is relatively small, suggesting a single meal or a small group. This $187.71 meals payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Radiology?

The payment is associated with a specific drug, Tagrisso, indicating a potential educational or promotional purpose.

What should patients do after learning about this payment?

This payment was for a meal provided by a pharmaceutical company, which may be related to information about a medication.

What else should I know about this meals payment?

The date of payment is in the future, which is unusual for reported data.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.